Literature DB >> 19439611

Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor.

Lei Zhang1, Sushuang Zheng, Haitao Wu, Yan Wu, Shuhong Liu, Ming Fan, Jian Zhang.   

Abstract

B lymphocyte stimulator (BLyS), a tumor necrosis factor family protein essential for B cell development, was previously shown to be expressed at an elevated level in the CNS of multiple sclerosis patients. Although it may be involved in CNS diseases, its exact functions in CNS remain unknown. We hypothesize that BLyS may be a negative regulator for neuronal functions. Here Nogo-66 receptor (NgR) is identified as a high affinity receptor for BLyS, which inhibits dorsal root ganglion outgrowth in culture. The inhibition by BLyS can be reversed by a truncated NgR or by removal of glycosylphosphatidylinositol-linked proteins from neurons. More importantly, the inhibitory effect by BLyS is significantly diminished for neurons isolated from NgR(-/-) mice. Furthermore, expressions of BLyS and NgR are also found to be associated with astrocytes and macrophages/microglial cells at spinal cord injury sites. Thus, BLyS can function independently of myelin-associated inhibitors and likely serves as a redundant NgR ligand that negatively influences axonal outgrowth in CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439611      PMCID: PMC6665512          DOI: 10.1523/JNEUROSCI.5040-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  28 in total

1.  LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.

Authors:  Rhalena Thomas; Kristy Favell; Jose Morante-Redolat; Madeline Pool; Christopher Kent; Melissa Wright; Kathleen Daignault; Gino B Ferraro; Samuel Montcalm; Yves Durocher; Alyson Fournier; Jordi Perez-Tur; Philip A Barker
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

Review 2.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 3.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

Review 4.  Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration.

Authors:  Oscar Seira; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2013-10-25       Impact factor: 5.590

Review 5.  Role of myelin-associated inhibitors in axonal repair after spinal cord injury.

Authors:  Jae K Lee; Binhai Zheng
Journal:  Exp Neurol       Date:  2011-05-07       Impact factor: 5.330

Review 6.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

Review 7.  Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Authors:  Harry Alexopoulos; Angie Biba; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 8.  Where no synapses go: gatekeepers of circuit remodeling and synaptic strength.

Authors:  Yevgeniya A Mironova; Roman J Giger
Journal:  Trends Neurosci       Date:  2013-05-02       Impact factor: 13.837

Review 9.  B cells in MS and NMO: pathogenesis and therapy.

Authors:  Markus Krumbholz; Edgar Meinl
Journal:  Semin Immunopathol       Date:  2014-05-16       Impact factor: 9.623

10.  Myelin-associated proteins block the migration of olfactory ensheathing cells: an in vitro study using single-cell tracking and traction force microscopy.

Authors:  Sara Nocentini; Diego Reginensi; Simón Garcia; Patricia Carulla; María Teresa Moreno-Flores; Francisco Wandosell; Xavier Trepat; Ana Bribian; José A del Río
Journal:  Cell Mol Life Sci       Date:  2011-12-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.